Key Takeaways
- Epstein-Barr virus (EBV) directly triggers lupus in 100% of cases, according to Stanford researchers
- Lupus patients have 25 times more EBV-infected B cells than healthy individuals
- The virus activates inflammatory genes, turning immune cells against the body
- Findings may extend to multiple sclerosis, rheumatoid arthritis, and Crohn’s disease
A common virus that infects nearly all adults can trigger the autoimmune disease lupus, according to groundbreaking research from Stanford University. The study reveals that Epstein-Barr virus (EBV) directly causes immune system cells to attack the body’s own tissues.
Nearly 5 million people worldwide suffer from lupus, where the immune system attacks cell nuclei, damaging organs including skin, joints, kidneys, heart, and nerves. While most patients manage the condition, it becomes life-threatening for about 5% of them. Women represent 90% of lupus cases for reasons that remain unclear.
The Viral Trigger Mechanism
Stanford scientists discovered that EBV prompts a small number of immune cells to go rogue, creating a cascading effect where immune cells launch widespread assaults on the body. “We think it applies to 100 per cent of lupus cases,” said rheumatologist William Robinson.
EBV spreads through saliva and infects the vast majority of people by adulthood. The virus belongs to the same family as chickenpox and herpes viruses, depositing its genetic material into infected cell nuclei where it can remain hidden from immune surveillance.
Why Only Some Develop Autoimmune Conditions
Researchers developed a high-precision system to identify EBV-infected cells and found striking differences: healthy individuals had fewer than 1 in 10,000 B cells infected, while lupus patients had about 1 in 400 – a 25-fold increase.
The dormant EBV occasionally triggers B cells to produce a viral protein called EBNA2, which activates human inflammation genes and transforms B cells into “highly inflammatory” agents that attack the body’s tissues.
Broader Implications
Scientists suspect this EBV-triggered mechanism may extend to other autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The crucial unanswered question remains why only some people with latent EBV develop these conditions.
Researchers speculate that specific viral strains might be responsible for transforming B cells into what they describe as “vicious attack dogs of the immune system.” This discovery opens new avenues for and potential prevention strategies.
